Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PHILADELPHIA, April 7, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an investor conference call and webcast to take place on Wednesday, April 9,...
-
PHILADELPHIA, April 7, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that it is accelerating a strategic initiative to explore the therapeutic potential for its...
-
PHILADELPHIA, March 18, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announces its financial results for the fiscal year ended December 31, 2007. The net loss for the year (including...
-
PHILADELPHIA, March 6, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced today that, following its submission of a clarifying amendment on January 9, 2008, to its NDA...
-
PHILADELPHIA, Feb. 25, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has accepted an invitation to present at the 2008 Emerging Growth Stock Conference, hosted...
-
PHILADELPHIA, Feb. 11, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has accepted an invitation to present at the 10th Annual BIO CEO & Investor...
-
PHILADELPHIA, Jan. 9, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced today that it has formally submitted to the United States Food & Drug Administration ("FDA") detailed...
-
PHILADELPHIA, Dec. 31, 2007 (PRIME NEWSWIRE) -- The Board of Directors of Hemispherx Biopharma, Inc. (AMEX:HEB) announces that, on December 26, 2007, certain executives were awarded bonuses of 25% of...
-
PHILADELPHIA, Dec. 27, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) reported today that the National Horizon Scanning Centre of the Department of Public Health and Epidemiology at...
-
PHILADELPHIA, Dec. 17, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an Investor Conference Call and webcast to take place on Wednesday, December...